Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pharmacyclics Gains ‘Breakthrough’ Status for Cancer Drug
Pharmacyclics Gains ‘Breakthrough’ Status for Cancer Drug
Pharmacyclics Gains ‘Breakthrough’ Status for Cancer Drug
Submitted by
admin
on February 13, 2013 - 10:11am
Source:
Bloomberg
News Tags:
Pharmacyclics
ibrutinib
JNJ
Headline:
Pharmacyclics Gains ‘Breakthrough’ Status for Cancer Drug
Do Not Allow Advertisers to Use My Personal information
